About the Company
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EBS News
Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement
Emergent Biosolutions Inc (NYSE:EBS) shares are trading higher after the company amended its existing credit agreement and ...
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
Q4 2023 total revenues were $276.6 million, a 16% decrease from Q4 2022. Net Loss: Q4 2023 net loss improved to $49.5 million ...
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript
Q4 2023 Earnings Call March 6, 2024 Emergent BioSolutions Inc. misses on earnings expectations. Reported EPS is $-0.77 EPS, ...
Emergent BioSolutions Enters Forbearance Agreement
Emergent BioSolutions has entered into a forbearance agreement with lenders. The company said in a regulatory filing ...
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
It indicates, "Click to perform a search". The word "Markets Insider". GAITHERSBURG, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for ...
Emergent BioSolutions Shares Drop on S&P Downgrade
By Dean Seal Shares of Emergent BioSolutions dropped after S&P Global Ratings downgraded the company's credit rating and the rating on its senior ...
Emergent Biosolutions: Q4 Earnings Snapshot
GAITHERSBURG, Md. — GAITHERSBURG, Md. — Emergent Biosolutions Inc. (EBS) on Wednesday reported a loss of $49.5 million in its fourth quarter. The Gaithersburg, Maryland-based company said it had a ...
Emergent BioSolutions Shares Slid 17% on Forbearance Agreement, 4Q Revenue Decline
Emergent BioSolutions shares fell 17% to $2.71 in premarket trading following a forbearance agreement as well as its latest quarterly results and outlook. The stock is down 70% over the last 12 months ...
Emergent BioSolutions upgraded to Buy at Benchmark after 'upbeat' Q4 report
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual ...
Benchmark gets more bullish on Emergent BioSolutions, upgrades shares
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual ...
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better-than-expected fourth-quarter financial results and issued strong revenue ...
Resonate Blends, Inc.: Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
NORTH BERGEN, NJ / ACCESSWIRE / March 15, 2024 / Resonate Blends, Inc. (OTCQB:KOAN) ("Resonate Blends" or the "Company") is pleased to report it has completed a Share Exchange Agreement with the holde ...
Loading the latest forecasts...